{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of Regn1979, An Anti-Cd20 X Anti-Cd3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma","item":"https:\/\/www.regionalcancercare.org\/trials\/an-open-label-study-to-assess-the-anti-tumor-activity-and-safety-of-regn1979-an-anti-cd20-x-anti-cd3-bispecific-antibody-in-patients-with-relapsed-or-refractory-follicular-lymphoma\/#breadcrumbitem"}]}